Patients with atrial fibrillation undergoing a disease-specific patient management intervention programme compared to standard care for the optimisation of health and well-being

Baker IDI Heart & Diabetes Institute0 个研究点目标入组 335 人开始时间: 2010年3月17日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•1. Documented diagnosis of sustained form of non-valvular atrial fibrillation
•2. A minimum of one hospitalisation (including index admission) related, at least in part, to atrial fibrillation
•3. Are living independently in the community or their own home post-hospitalisation
•4. Are able and willing to provide written informed consent to participate in the trial

•1. Aged below 45 years
•2. Have a diagnosis of valvular atrial fibrillation
•3. Are scheduled for a catheter ablation for treatment of atrial fibrillation
•4. Have evidence of pre-existing New York Heart Association (NYHA) Class III-IV with a documented left ventricular ejection fraction less than 45%
•5. Have alcohol-induced atrial fibrillation
•6. Have transient forms of atrial fibrillation associated with acute myocardial infarction and/or pericarditis
•7. Have a terminal condition or malignancy requiring palliative care
•8. Cannot adequately provide written informed consent to participate
•9. Have any other medical condition that results in the belief that it is not appropriate for the patient to embark on participation within this study

发起方

Baker IDI Heart & Diabetes Institute